No abstract

No abstract

No abstract

Poly(glycerol sebacate) (PGS) is an elastomer with potential biomedical applications but it suffers from problems with irreproducible synthesis and the unacceptable toxicity of very soft PGS elastomers. To establish the reason for these problems, PGS was synthesized using different temperatures and reaction times, and the reaction was monitored by titration of the unreacted carboxylic groups and measurement of the mass loss during synthesis. It was found that evaporation of glycerol was a major cause of irreproducibility of the elastomer synthesis and this was more significant at higher reaction temperatures. The polymer microstructure was analysed using NMR spectroscopy and all twelve acylglyceride 13C‐signals as well as two small extra peaks of the residual glycerol were observed for the pre‐polymer. For the PGS gel, the glyceride moieties were characterized using NMR spectroscopy for the first time. The modulus and ultimate tensile strength of the gel increased with longer cure times and at higher cure temperatures while the elongation to break decreased and this was interpreted in terms of network theory. The cell viability of mouse fibroblasts was better for PGS samples with a higher conversion.© 2012 Society of Chemical Industry

Grafting of elastomeric biomaterial scaffolds may offer a radical strategy for the prevention of heart failure after myocardial infarction by increasing efficacy of stem cell delivery as well as acting as mechanical restraint devices to constrain scar expansion. Biomaterials can be partially optimized in vitro, but their in vivo performance is most critical and should ideally be monitored serially and noninvasively. We used magnetic resonance imaging (MRI) to assess three scaffold materials with a range of structural moduli equal to or greater than myocardial tissue: poly(glycerol sebacate) (PGS), poly(ethyleneterephathalate)/dimer fatty acid (PED), and TiO(2)-reinforced PED (PED-TiO(2)). Patches, 1  cm in diameter, were grafted onto the hearts of infarcted rats, with biomaterial-free infarcted rat hearts used as controls. MRI was able to determine scaffold size and location on the heart and identified unexpectedly rapid in vivo degradation of the PGS compared with previous in vitro testing. PED patches did not withstand in vivo attachment, but the more rigid PED-TiO(2) material was detrimental to heart function, increasing chamber and scar sizes and reducing ejection fractions compared with controls. In contrast, the mechanically compatible PGS scaffold successfully reduced hypertrophy, giving it potential for limiting excessive postinfarct remodeling. PGS was unable to support systolic function, but it would be suitable for strategies to deliver cardiac stem/progenitor cells, to limit remodeling during the period of functional cellular integration, and to degrade after cell assimilation by the heart. This work has also shown for the first time the value of using MRI as a noninvasive tool for evaluating and optimizing therapeutic biomaterials in vivo.